Across three cohorts of patients with systemic sclerosis, the DNASE1L3 R206C loss-of-function variant was associated with higher mortality (n=2366; HR 1.16, 95% CI 1.02–1.32) and precapillary pulmonary hypertension (n=1170; HR 1.69, 1.31–2.19), mostly without ILD.
Meta-analysisn = 2,366
Skaug et al. Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant